Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Mahé

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Cancers|June 10, 2023
Diagnostic Approach for Venous Thromboembolism in Cancer PatientsHélène Helfer, Yara Skaff, Florent Happe, et al.
Archives of Cardiovascular Diseases|December 8, 2023
Recurrent venous thromboembolism in anticoagulated cancer patients: Diagnosis and treatmentLaurent Bertoletti, Philippe Girard, Antoine Elias, et al.
Cancers|June 10, 2023
Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in FranceLaurent Bertoletti, Gaelle Gusto, Nadia Quignot, et al.
Therapeutic Drug Monitoring|May 29, 2004
Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustmentJean-Sébastien Hulot, Clarisse Vantelon, Saïk Urien, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 15, 2007
Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin?Isabelle Gouin-Thibault, Eric Pautas, Isabelle Mahé, et al.
Archives of Cardiovascular Diseases|December 10, 2023
Treatment of cancer-associated venous thromboembolism in patients under palliative carePhilippe Debourdeau, Marie-Antoinette Sevestre, Laurent Bertoletti, et al.
Cancers|April 23, 2022
In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis PatientsGéraldine Poénou, Emmanuel Tolédano, Hélène Helfer, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patientsStéphane Mouly, Nathalie Rizzo-Padoin, Guy Simoneau, et al.
Patient Preference and Adherence|January 31, 2018
Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillationMichaël Benzimra, Béatrix Bonnamour, Martin Duracinsky, et al.
Frontiers in Cardiovascular Medicine|September 6, 2023
Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic eventsGéraldine Poénou, Emmanuel Tolédano, Hélène Helfer, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Cancers|June 10, 2023
Diagnostic Approach for Venous Thromboembolism in Cancer PatientsHélène Helfer, Yara Skaff, Florent Happe, et al.
Archives of Cardiovascular Diseases|December 8, 2023
Recurrent venous thromboembolism in anticoagulated cancer patients: Diagnosis and treatmentLaurent Bertoletti, Philippe Girard, Antoine Elias, et al.
Cancers|June 10, 2023
Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in FranceLaurent Bertoletti, Gaelle Gusto, Nadia Quignot, et al.
Therapeutic Drug Monitoring|May 29, 2004
Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustmentJean-Sébastien Hulot, Clarisse Vantelon, Saïk Urien, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 15, 2007
Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin?Isabelle Gouin-Thibault, Eric Pautas, Isabelle Mahé, et al.
Archives of Cardiovascular Diseases|December 10, 2023
Treatment of cancer-associated venous thromboembolism in patients under palliative carePhilippe Debourdeau, Marie-Antoinette Sevestre, Laurent Bertoletti, et al.
Cancers|April 23, 2022
In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis PatientsGéraldine Poénou, Emmanuel Tolédano, Hélène Helfer, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patientsStéphane Mouly, Nathalie Rizzo-Padoin, Guy Simoneau, et al.
Patient Preference and Adherence|January 31, 2018
Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillationMichaël Benzimra, Béatrix Bonnamour, Martin Duracinsky, et al.
Frontiers in Cardiovascular Medicine|September 6, 2023
Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic eventsGéraldine Poénou, Emmanuel Tolédano, Hélène Helfer, et al.
Pageof 15